p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer

Clinical trial NCT00525200 · COMPLETED

Trial details

NCT number: NCT00525200
Sponsor: Daniela Kandioler
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2007-06-01
Primary completion: 2012-05-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.